Circulation: Heart Failure, Ahead of Print. Background:Prospective studies demonstrate that aggressive pharmacological therapy combined with pump speed optimization may result
Read moreFrances S. de Man Correspondence to: Frances S. de Man, PhD, Department of Pulmonary Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam,
Read moreCirculation: Heart Failure, Ahead of Print. Background:Regulatory and clinical decisions involving health technologies require judgements about relative importance of their
Read moreSadiya S. Khan Correspondence to: Sadiya S. Khan, MD, MSc, Northwestern University, Feinberg School of Medicine, 680 N Lakeshore Dr,
Read moreBackground: Epicardial adipose tissue (EAT) accumulation is thought to play a role in the pathophysiology of heart failure (HF) with
Read moreBackground: Prescriptions of off-label under- and overdosing of direct oral anticoagulants (DOACs) are common for patients with atrial fibrillation, but
Read more
Background: Termination of a clinical trial before the maximum planned sample size is accrued can occur for multiple valid reasons
Read moreScience isn’t finished until it’s communicated. —Mark Walport, former UK Chief Scientific Advisor Scientific communication is not easy. Yet the
Read more
Circulation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/14/12″>Volume 14, Issue 12</a>, December 1, 2021. Source link
Read moreBackground: Tafamidis is approved in many countries for the treatment of transthyretin amyloid cardiomyopathy. This study reports data on the
Read more
